|
Mechanisms of hypotensive effects of 3-((4-(2-methoxy-phenyl)piperazin-l-ly)methylthio)-2, 3-dihydroimidazo (1, 2-c)quinazoline (DL-017), a synthesized quinazoline derivative, were studied in anaesthetized Sprague-Dawley (SD) rats and spontaneously hypertensive rats (SHR).Intravenous administration of DL-017 or prazosin resulted in falls in systemic arterial blood pressure (SAP) and, except initial transient increase in some preparations, heart rate (HR) in both SD and SHR.At a dose of 0.1 mg/kg, DL-017 exerted a maximal hypotensive effect. Phenylephrine (PHE) (3*g/kg) or angiotensinⅡ (AⅡ) (0.1 *g/kg) induced a transient increase in SAP with a reflex bradycardia, while Nω-nitro-L-arginine (L-NNA, a potent nitric oxide synthase inhibitor) (30 mg/kg)produced a long-lasting increase in SAP and decrease in HR. DL-017 as well as prazosin selectively antagonized the pressor effect of PHE, but not that of AⅡ or L-NNA. In comparison with prazosin, DL-017 enhanced reflex bradycardia in response to pressor effect of AⅡ. These results suggest that DL-017, similar to prazosin, exerts an α1-antagonistic action to lower blood pressure and functionally attenuates the hypertensive effect from stimulation of AⅡ receptor and inhibition of nitric oxide synthase.
|